earnings
confidence high
sentiment positive
materiality 0.75
Outset Medical Q1 revenue $30.6M (+33% YoY); narrows FY2022 guidance to $144M-$150M
Outset Medical, Inc.
2023-Q1 EPS reported
-$0.78
revenue$30,550,000
- Revenue $30.6M (+33.3% YoY); product revenue $25.7M (+40.9%).
- GAAP gross margin 14.5% vs 1.3% YoY; non-GAAP gross margin 14.8%.
- GAAP net loss ($36.9M) or ($0.78)/share; non-GAAP net loss ($31.9M) or ($0.67)/share.
- FY2022 revenue guidance narrowed to $144M-$150M (prior $142M-$150M), 40-46% growth.
- Appointed Dale E. Jones to Board; cash $335.6M; record Tablo Home console shipments.